Vol. 28 No. 1 (2024)
EXPERIMENTAL STUDIES

Frequency and amplitude structure of ventricular fibrillation of canine heart during ischemia and reperfusion: an experimental study

PDF (Русский)
  • M.I. Gurianov,
  • E.A. Kharitonova,
  • P.K. Yablonskiy
M.I. Gurianov
Saint Petersburg Research Institute of Phthisiopulmonology, Saint Petersburg; Saint Petersburg State University, Saint Petersburg
Bio
E.A. Kharitonova
Saint Petersburg State University, Saint Petersburg
P.K. Yablonskiy
Saint Petersburg Research Institute of Phthisiopulmonology, Saint Petersburg; Saint Petersburg State University, Saint Petersburg
DOI: https://doi.org/10.21688/1681-3472-2024-1-50-58

Published 2024-05-22

Keywords

  • Animals,
  • Dogs,
  • Myocardial Ischemia,
  • Myocardial Reperfusion,
  • Perfusion,
  • Ventricular Fibrillation
    • ...More
    Less

How to Cite

Gurianov, M., Kharitonova, E., & Yablonskiy, P. (2024). Frequency and amplitude structure of ventricular fibrillation of canine heart during ischemia and reperfusion: an experimental study. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 28(1), 50–58. https://doi.org/10.21688/1681-3472-2024-1-50-58

Copyright (c) 2024 Gurianov M.I., Kharitonova E.A., Yablonskiy P.K.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Introduction: Ventricular fibrillation (VF) is a fatal arrhythmia that causes sudden cardiac death in the overwhelming majority of cases (> 80%).
Objective: The study was aimed to examine frequency and amplitude structure of VF upon canine heart reperfusion after ischemia within 30–240 s.
Methods: Six experiments were conducted on 12 dogs. In each experiment the isolated heart of the one dog was perfused with the blood of the other (supporting) dog. Nine episodes of heart ischemia, lasting 30, 60, 90, 120, 150, 180, 210 and 240 s, were examined in six experiments (72 episodes of heart ischemia at VF in total). Before and after each ischemia episode, ten-minute perfusion and reperfusion were performed at VF, and heart electrograms were recorded. Spectral analysis of electrograms was conducted using Fast Fourier Transform in the range of 0.5–15 Hz. The frequency and proportions of the 1st through the 3rd oscillations of the most powerful frequencies were determined during perfusion, ischemia and reperfusion of the heart at VF (frequency (Hz) — mode; proportions (%) — M±SD; n = 270).
Results: The frequency and proportions of the dominant oscillations were stable at perfusion and amounted to 9–10 Hz and 39–41%, respectively, without significant changes after 30-second ischemia (P = 0.09; P = 0.07) and 10-minute reperfusion (from P = 0.07 to P = 0.23; from P = 0.09 to P = 0.21). At the 2nd min of ischemia, the frequency of dominant oscillations decreased to 8.5–9.0  Hz (P = 0.009) but their proportions did not change significantly (P = 0.06). At the 3-4th min of ischemia, the frequency of dominant oscillations decreased to 5.0-7.5 Hz (P = 0.002), and their proportions reduced to 32-33% (P = 0.001). During reperfusion, after 1–2-minute ischemia, the frequency of the dominant oscillations increased to 10.5–12.0 Hz (P = 0.03 and P = 0.002) at the 1st min and decreased to 9.5–10.5 Hz (P = 0.01 and P = 0.009) at the 2nd min of reperfusion processes. After 3–4 minute ischemia, the frequency of dominant oscillations increased to 12.5–14.0 Hz (P = 0.001) at the 1st min and decreased to 10–11 Hz (P = 0.005 and P = 0.007) at the 2nd min of reperfusion processes. Further, the proportions of dominant oscillations after 1–2-minute ischemia decreased to 33–36% (P = 0.003 and P = 0.002) at the 1st min and increased to 39% (P = 0.005 and P = 0.001) at the 2nd min of reperfusion. After 3–4-minute ischemia, the proportion of dominant oscillations remained reduced (32–34%) at the 1st min but increased to 36–40% (P = 0.005 and P = 0.007) at the 2nd min during reperfusion.
Conclusion: The organized VF activity was more sensitive to reperfusion than to ischemia, as evidenced by more significant changes in the VF frequency and amplitude structure at reperfusion relative to ischemia. VF was specified by explosive (impulse) destabilization of the organized activity at reperfusion, which manifested itself by an increase in the frequency of dominant FV oscillations at the 1st min and their decrease at 2–3th min of reperfusion process, as well as by a decrease in the proportions of dominant VF oscillations at the 1st min and their increase at 2–3th min at reperfusion. The severity of destabilization of the organized VF activity at reperfusion positively associated with the ischemia duration.

Received 26 February 2024. Revised 22 April 2024. Accepted 23 April 2024.

Funding: The study did not have sponsorship.

Conflict of interest: The authors declare no conflict of interest.

Contribution of the authors: The authors contributed equally to this article.

Acknowledgment: The authors thank Inkart LLC (Saint Petersburg, Russian Federation) and Family Doctor Clinic (AntMed LLC, Saint Petersburg, Russian Federation) for their assistance in the study.

PDF (Русский)

References

  1. Лебедев Д.С., Михайлов Е.Н., Неминущий Н.М., Голухова Е.З., Бабокин В.Е., Березницкая В.В., Васичкина Е.С., Гарькина С.В., Голицын С.П., Давтян К.В., Дупляков Д.В., Заклязьминская Е.В., Зенин С.А., Иваницкий Э.А., Ильдарова Р.А.-Г., Комолятова В.Н., Костарева А.А., Кучинская Е.А., Лайович (Нестеренко) Л.Ю., Лебедева В.К., Любимцева Т.А., Макаров Л.М., Мамчур С.Е., Медведев М.М., Миронов Н.Ю., Митрофанова Л.Б., Попов С.В., Ревишвили А.Ш., Рзаев Ф.Г., Романов А.Б., Татарский Р.Б., Термосесов С.А., Уцумуева М.Д., Харлап М.С., Царегородцев Д.А., Школьникова М.А., Шлевков Н.Б., Шляхто Е.В., Шубик Ю.В., Яшин С.М. Желудочковые нарушения ритма. Желудочковые тахикардии и внезапная сердечная смерть. Клинические рекомендации 2020. Российский кардиологический журнал. 2021;26(7):4600. https://doi.org/10.15829/1560-4071-2021-4600 Lebedev D.S., Mikhailov E.N., Neminuschiy N.M., Golukhova E.Z., Babokin V.E., Bereznitskaya V.V., Vasichkina E.S., Garkina S.V., Golitsyn S.P., Davtyan K.V., Duplyakov D.V., Zaklyazminskaya E.V., Zenin S.A., Ivanitsky E.A., Ildarova R.A., Komolyatova V.N., Kostareva A.A., Kuchinskaya E.A., Lajovich (Nesterenko) L.Yu., Lebedeva V.K., Lyubimtseva T.A., Makarov L.M., Mamchur S.E., Medvedev M.M., Mironov N.Yu., Mitrofanova L.B., Popov S.V., Revishvili A.Sh., Rzayev F.G., Romanov A.B., Tatarsky R.B., Termosesov S.A., Utsumueva M.D., Kharlap M.S., Tsaregorodtsev D.A., Shkolnikova M.A., Shlevkov N.B., Shlyakhto E.V., Shubik Yu.V., Yashin S.M. Ventricular arrhythmias. Ventricular tachycardias and sudden cardiac death. 2020 Clinical guidelines. Rossiysky kardiologichesky zhurnal = Russian Journal of Cardiology. 2021;26(7):4600. (In Russ.) https://doi.org/10.15829/1560-4071-2021-4600
  2. Zeppenfeld K., Tfelt-Hansen J., de Riva M., Winkel B.G., Behr E.R., Blom N.A., Charron P., Corrado D., Dagres N., de Chillou C., Eckardt L., Friede T., Haugaa K.H., Hocini M., Lambiase P.D., Marijon E., Merino J.L., Peichl P., Priori S.G., Reichlin T., Schulz-Menger J., Sticherling C., Tzeis S., Verstrael A., Volterrani M.; ESC Scientific Document Group. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43(40):3997-4126. PMID: 36017572. https://doi.org/10.1093/eurheartj/ehac262
  3. Tsao C.W., Aday A.W., Almarzooq Z.I., Anderson C.A.M., Arora P., Avery C.L., Baker-Smith C.M., Beaton A.Z., Boehme A.K., Buxton A.E., Commodore-Mensah Y., Elkind M.S.V., Evenson K.R., Eze-Nliam C., Fugar S., Generoso G., Heard D.G., Hiremath S., Ho J.E., Kalani R., Kazi D.S., Ko D., Levine D.A., Liu J., Ma J., Magnani J.W., Michos E.D., Mussolino M.E., Navaneethan S.D., Parikh N.I., Poudel R., Rezk-Hanna M., Roth G.A., Shah N.S., St-Onge M.-P., Thacker E.L., Virani S.S., Voeks J.H., Wang N.-Y., Wong N.D., Wong S.S., Yaffe K., Martin S.S.; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2023 update: a report from the American Heart Association. Circulation. 2023;147(8):e93-e621. PMID: 36695182. https://doi.org/10.1161/CIR.0000000000001123
  4. Panitchob N., Li L., Huang J., Ranjan R., Ideker R.E., Dosdall D.J. Endocardial activation drives activation patterns during long-duration ventricular fibrillation and defibrillation. Circ Arrhythm Electrophysiol. 2017;10(12):e005562. PMID: 29247031; PMCID: PMC5737741. https://doi.org/10.1161/CIRCEP.117.005562
  5. Cheng K.-A., Dosdall D.J., Li L., Rogers J.M., Ideker R.E., Huang J. Evolution of activation patterns during long-duration ventricular fibrillation in pigs. Am J Physiol Heart Circ Physiol. 2012;302(4):H992-H1002. PMID: 22180655; PMCID: PMC3322740. https://doi.org/10.1152/ajpheart.00419.2011
  6. Venable P.W., Taylor T.G., Shibayama J., Warren M., Zaitsev A.V. Complex structure of electrophysiological gradients emerging during long-duration ventricular fibrillation in the canine heart. Am J Physiol Heart Circ Physiol. 2010;299(5):H1405-H1418. PMID: 20802138; PMCID: PMC2993199. https://doi.org/10.1152/ajpheart.00419.2010
  7. Szabó Z., Ujvárosy D., Ötvös T., Sebestyén V., Nánási P.P. Handling of ventricular fibrillation in the emergency setting. Front Pharmacol. 2020;10:1640. PMID: 32140103; PMCID: PMC7043313. https://doi.org/10.3389/fphar.2019.01640
  8. Яблонский П.К., Гурьянов М.И. Организованная активность фибрилляции желудочков собаки при реперфузии после одноминутной ишемии сердца. Вестник Санкт-Петербургского университета. Медицина. 2023;18(2):141-149. https://doi.org/10.21638/spbu11.2023.203 Yablonsky P.K., Gurianov M.I. Organized activity of canine ventricular fibrillation under reperfusion after 1-minute ischemia of the heart. Vestnik of Saint Petersburg University. Medicine. 2023;18(2):141-149. (In Russ.) https://doi.org/10.21638/spbu11.2023.203
  9. Гурьянов М.И., Яблонский П.К. Дестабилизация организованной структуры фибрилляции желудочков при реперфузии. Общая реаниматология. 2023;19(5):59-64. https://doi.org/10.15360/1813-9779-2023-5-2338 Gurianov M.I., Yablonsky P.K. Destabilization of the organized structure of ventricular fibrillation during reperfusion. Obshchaya reanimatologiya = General Reanimatology. 2023;19(5):59-64. (In Russ.) https://doi.org/10.15360/1813-9779-2023-5-2338
  10. Bradley C.P., Clayton R.H., Nash M.P., Mourad A., Hayward M., Paterson D.J., Taggart P. Human ventricular fibrillation during global ischemia and reperfusion. Paradoxical changes in activation rate and wavefront complexity. Circ Arrhythm Electrophysiol. 2011;4(5):684-691. PMID: 21841193. https://doi.org/10.1161/CIRCEP.110.961284
  11. Xing C., Jin Q., Zhang N., Liu S., Lin C., Wu Q., Luo Q., Liu A., Wu L. Effect of flunarizine on defibrillation outcomes and early refibrillation in a canine model of prolonged ventricular fibrillation. Exp Physiol. 2019;104(11):1630-1637. PMID: 31465138; PMCID: PMC6899960. https://doi.org/10.1113/EP087068
  12. Perkins G.D., Graesner J.-T., Semeraro F., Olasveengen T., Soar J., Lott C., Van de Voorde P., Madar J., Zideman D., Mentzelopoulos S., Bossaert L., Greif R., Monsieurs K., Svavarsdóttir H., Nolan J.P.; European Resuscitation Council Guideline Collaborators. European Resuscitation Council guidelines 2021: Executive summary. Resuscitation. 2021;161:1-60. PMID: 33773824. https://doi.org/10.1016/j.resuscitation.2021.02.003
  13. Sattler S.M., Skibsbye L., Linz D., Lubberding A.F., Tfelt-Hansen J., Jespersen T. Ventricular arrhythmias in first acute myocardial infarction: Epidemiology, mechanisms, and interventions in large animal models. Front Cardiovasc Med. 2019;6:158. PMID: 31750317; PMCID: PMC6848060. https://doi.org/10.3389/fcvm.2019.00158
  14. Самойлов В.О. Медицинская биофизика: учеб. для вузов. СПб.: СпецЛит, 2013. С. 166-203. Samoilov V.O. Medical Biophysics. Textbook. Saint-Petersburg: SpetsLit Publ.; 2013. P. 166-203. (In Russ.)
  15. Nelson D.L., Cox M.M. Oxidative phosphorylation and photophosphorilation. In: Nelson D.L., Cox M.M. Lehninger Principles of Biochemistry. New York: W.H. Freeman and Company; 2014. P. 707-772.
  16. Hansen H.M., Sadredini M., Hasic A., Eriksen M., Stokke M.K. Myocardial oxidative stress is increased in early reperfusion, but systemic antioxidative therapy does not prevent ischemia-reperfusion arrhythmias in pigs. Front Cardiovasc Med. 2023;10:1223496. PMID: 37823177; PMCID: PMC10562584. https://doi.org/10.3389/fcvm.2023.1223496
  17. Prag H.A., Murphy M.P., Krieg T. Preventing mitochondrial reverse electron transport as a strategy for cardioprotection. Basic Res Cardiol. 2023;118(1):34. PMID: 37639068; PMCID: PMC10462584. https://doi.org/10.1007/s00395-023-01002-4
  18. Jung J.C., Kim S.-I., Hwang H.Y., Sohn S.H., Choi J.W., Chung J.-H., Seo J.-W., Kim K.-B. Serial ultrastructural evaluation of myocardial ischemic injury after infusion of del Nido cardioplegia in the human heart. J Thorac Cardiovasc Surg. 2022;164(2):528-535. PMID: 33008580. https://doi.org/10.1016/j.jtcvs.2020.08.083
  19. Saclı H., Kara I., Diler M.S., Percin B., Turan A.I., Kırali K. The relationship between the use of cold and isothermic blood cardioplegia solution for myocardial protection during cardiopulmonary bypass and the ischemia–reperfusion injury. Ann Thorac Cardiovasc Surg. 2019;25(6):296-303. PMID: 31308305; PMCID: PMC6923728. https://doi.org/10.5761/atcs.oa.18-00293
  20. Nakai C., Zhang C., Kitahara H., Shults C., Waksman R., Molina E.J. Outcomes of del Nido cardioplegia after surgical aortic valve replacement and coronary artery bypass grafting. Gen Thorac Cardiovasc Surg. 2023;71(9):491-497. PMID: 36843184. https://doi.org/10.1007/s11748-023-01914-x
  21. Krasniqi L., Ipsen M.H., Schrøder H.D., Hejbøl E.K., Rojek A.M., Kjeldsen B.J., Riber L.P. Stone heart syndrome after prolonged cardioplegia induced cardiac arrest in open-heart surgery — a pilot study on pigs. Cardiovasc Pathol. 2022;60:107427. PMID: 35436604. https://doi.org/10.1016/j.carpath.2022.107427
  22. Whittaker A., Aboughdir M., Mahbub S., Ahmed A., Harky A. Myocardial protection in cardiac surgery: how limited are the options? A comprehensive literature review. Perfusion. 2021;36(4):338-351. PMID: 32736492. https://doi.org/10.1177/0267659120942656